Search Results for: COL6A1

24 interactions involving COL6A1 - collagen type VI alpha 1 chain found:

Interactant Symbol Name
Associated Pathways
Binding Drugs
Associated Diseases
ALDH3A2 aldehyde dehydrogenase 3 family member A2
  • NADH
  • Sjogren-Larsson syndrome
CFAP410 cilia and flagella associated protein 410
COL2A1 collagen type II alpha 1 chain
  • Collagen degradation
  • Collagen degradation
  • Extracellular matrix organization
  • Collagen biosynthesis and modifying enzymes
  • Signaling by PDGF
  • Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell
  • Assembly of collagen fibrils and other multimeric structures
  • Integrin cell surface interactions
  • Integrin cell surface interactions
  • Non-integrin membrane-ECM interactions
  • ECM proteoglycans
  • ECM proteoglycans
  • NCAM1 interactions
  • MET activates PTK2 signaling
  • Collagen chain trimerization
  • Collagenase clostridium histolyticum
  • Type II collagenopathies, including: Achondrogenesis II; Hypochondrogenesis; SED congenita; SMED Strudwick type; Kniest dysplasia; Spondyloperipheral dysplasia; Osteoarthritis with mild chondrodysplasia; Stickler syndrome 1; Platyspondylic skeletal dysplasia, Torrance type; Epiphyseal dysplasia, multiple, with myopia and deafness; Czech dysplasia
  • Vitreoretinal degeneration, including: Stickler syndrome type I (STL1); Stickler syndrome type II (STL2); Snowflake vitreoretinal degeneration (SVD); Wagner syndrome 1 (WGN1); Knobloch syndrome (KNO); Enhanced S-cone syndrome (ESCS); Autosomal dominant vitreoretinochoroidopathy (ADVIRC)
  • Osteoarthritis with mild chondrodysplasia
COL6A2 collagen type VI alpha 2 chain
  • Collagen degradation
  • Collagen biosynthesis and modifying enzymes
  • Signaling by PDGF
  • Assembly of collagen fibrils and other multimeric structures
  • Integrin cell surface interactions
  • ECM proteoglycans
  • ECM proteoglycans
  • NCAM1 interactions
  • Collagen chain trimerization
  • Congenital muscular dystrophies (CMD/MDC), including: Merosin-deficient CMD (MDC1A); Ullrich CMD (UCMD); Integrin alpha7-deficient CMD; CMD with joint hyperlaxity (CMDH); CMD with epidermolysis bullosa; Walker-Warburg syndrome (WWS); Muscle-eye-brain disease (MEB); Fukuyama CMD (FCMD); CMD with muscle hypertrophy (MDC1C); CMD with severe intellectual impairment and abnormal glycosylation (MDC1D); Rigid spine syndrome (RSS); LMNA-deficient CMD; CMD with respiratory failure and muscle hypertrophy (MDC1B); Bethlem myopathy
CSTB cystatin B
  • Neutrophil degranulation
  • Cupric Chloride
  • Progressive myoclonic epilepsy (PME), including: Lafora disease (LBD); Unverricht-Lundborg disease (ULD); Neuronal ceroid lipofuscinoses (NCL); Type I sialidosis; Action myoclonus-renal failure syndrome (AMRF); Type III Gaucher disease (GD)
DCN decorin
  • Degradation of the extracellular matrix
  • A tetrasaccharide linker sequence is required for GAG synthesis
  • Chondroitin sulfate biosynthesis
  • Dermatan sulfate biosynthesis
  • CS/DS degradation
  • ECM proteoglycans
  • ECM proteoglycans
  • Defective B4GALT7 causes EDS, progeroid type
  • Defective B3GAT3 causes JDSSDHD
  • Defective CHST3 causes SEDCJD
  • Defective CHST14 causes EDS, musculocontractural type
  • Defective CHSY1 causes TPBS
  • Defective B3GALT6 causes EDSP2 and SEMDJL1
  • Tromethamine
  • Congenital stromal corneal dystrophy (CSCD); Congenital hereditary stromal dystrophy; Witschel dystrophy
DNAJB11 DnaJ heat shock protein family (Hsp40) member B11
  • XBP1(S) activates chaperone genes
FAM3B FAM3 metabolism regulating signaling molecule B
FGF7 fibroblast growth factor 7
  • PI3K Cascade
  • PIP3 activates AKT signaling
  • FGFR2b ligand binding and activation
  • Activated point mutants of FGFR2
  • Constitutive Signaling by Aberrant PI3K in Cancer
  • Phospholipase C-mediated cascade; FGFR2
  • PI-3K cascade:FGFR2
  • SHC-mediated cascade:FGFR2
  • FRS-mediated FGFR2 signaling
  • Negative regulation of FGFR2 signaling
  • Signaling by FGFR2 in disease
  • RAF/MAP kinase cascade
  • PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling
HCFC2 host cell factor C2
LAMB1 laminin subunit beta 1
  • Degradation of the extracellular matrix
  • Laminin interactions
  • Laminin interactions
  • Non-integrin membrane-ECM interactions
  • ECM proteoglycans
  • L1CAM interactions
  • Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs)
  • MET activates PTK2 signaling
  • Post-translational protein phosphorylation
  • EGR2 and SOX10-mediated initiation of Schwann cell myelination
LCMT2 leucine carboxyl methyltransferase 2
  • Synthesis of wybutosine at G37 of tRNA(Phe)
  • Synthesis of wybutosine at G37 of tRNA(Phe)
  • L-Leucine
LGALS3BP galectin 3 binding protein
  • Platelet degranulation
MAG myelin associated glycoprotein
  • Axonal growth inhibition (RHOA activation)
  • Basigin interactions
  • EGR2 and SOX10-mediated initiation of Schwann cell myelination
MLLT3 MLLT3 super elongation complex subunit
  • Formation of RNA Pol II elongation complex
  • RNA Polymerase II Pre-transcription Events
  • RNA Polymerase II Transcription Elongation
MPRIP myosin phosphatase Rho interacting protein
  • Signaling by BRAF and RAF fusions
MTDH metadherin
PCNT pericentrin
  • Regulation of PLK1 Activity at G2/M Transition
  • Loss of Nlp from mitotic centrosomes
  • Recruitment of mitotic centrosome proteins and complexes
  • Loss of proteins required for interphase microtubule organization from the centrosome
  • Recruitment of NuMA to mitotic centrosomes
  • Anchoring of the basal body to the plasma membrane
  • AURKA Activation by TPX2
  • Chaperone Mediated Autophagy
  • Late endosomal microautophagy
  • Aggrephagy
  • Aggrephagy
  • Microcephalic osteodysplastic primordial dwarfism, type II (MOPD II)
  • Seckel syndrome
PDGFA platelet derived growth factor subunit A
  • Non-integrin membrane-ECM interactions
  • Malignant pleural mesothelioma
  • Glioma
PDGFB platelet derived growth factor subunit B
  • Platelet degranulation
  • PIP3 activates AKT signaling
  • Downstream signal transduction
  • Signaling by PDGF
  • Constitutive Signaling by Aberrant PI3K in Cancer
  • Non-integrin membrane-ECM interactions
  • RAF/MAP kinase cascade
  • PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling
  • Malignant pleural mesothelioma
  • Glioma
PDK1 pyruvate dehydrogenase kinase 1
  • Regulation of pyruvate dehydrogenase (PDH) complex
  • Signaling by Retinoic Acid
  • 4-[(3-CHLORO-4-{[(2R)-3,3,3-TRIFLUORO-2-HYDROXY-2-METHYLPROPANOYL]AMINO}PHENYL)SULFONYL]-N,N-DIMETHYLBENZAMIDE
  • Dichloroacetic Acid
PEX26 peroxisomal biogenesis factor 26
  • Peroxisomal protein import
  • Peroxisomal protein import
  • Class I peroxisomal membrane protein import
  • Zellweger syndrome spectrum, including: Zellweger syndrome (ZS); Adrenoleukodystrophy, neonatal (NALD); Infantile Refsum disease (IRD)
PIGS phosphatidylinositol glycan anchor biosynthesis class S
  • Attachment of GPI anchor to uPAR
RUNX1 RUNX family transcription factor 1
  • Pre-NOTCH Transcription and Translation
  • Organic cation transport
  • RUNX1 and FOXP3 control the development of regulatory T lymphocytes (Tregs)
  • RUNX1 regulates estrogen receptor mediated transcription
  • Regulation of RUNX1 Expression and Activity
  • Regulation of RUNX1 Expression and Activity
  • RUNX1 regulates expression of components of tight junctions
  • RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function
  • RUNX1 regulates transcription of genes involved in differentiation of HSCs
  • RUNX1 regulates transcription of genes involved in differentiation of HSCs
  • RUNX1 regulates transcription of genes involved in differentiation of keratinocytes
  • RUNX1 regulates transcription of genes involved in differentiation of keratinocytes
  • RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known
  • RUNX1 regulates transcription of genes involved in BCR signaling
  • RUNX1 regulates transcription of genes involved in differentiation of myeloid cells
  • RUNX1 regulates transcription of genes involved in interleukin signaling
  • RUNX1 regulates transcription of genes involved in WNT signaling
  • RUNX2 regulates genes involved in differentiation of myeloid cells
  • RUNX3 regulates p14-ARF
  • Estrogen-dependent gene expression
  • Transcriptional regulation of granulopoiesis
  • Chronic myeloid leukemia (CML)
  • Thrombocytopenia (THC); Familial platelet disorder with associated myeloid malignancy (FPDMM)
  • Acute myeloid leukemia (AML)
  • Acute lymphoblastic leukemia (ALL) (precursor B lymphoblastic leukemia)